Find Your Funding Opportunity
Provider’s Clinical Support System – Medication Assisted Treatment Grant
Service
|
Source |
Final Application Due Date |
Funding Available
|
Match Required
|
|---|---|---|---|---|
| Health Care |
Federal
HHS |
See FOA | $2.0 M | No Match Required |
-
Service
-
Source
-
Final Application Due Date
-
Funding Available
-
Match Required
Status
- Expected Number of Awards 1
- Opportunity Type Discretionary
-
CFDA
93.243 -- Substance Abuse and Mental Health Services Projects of Regional and National Significance
Description
The purpose of this SAMHSA grant program is to expand training for primary care providers in the evidence-based prevention and treatment of opioid use disorders (OUD) and the treatment of chronic pain, increase understanding of the importance of medication-assisted treatment (MAT) and ultimately increase access to MAT through expanded prescribing of FDA-approved medications for the treatment of opioid use disorders.
Eligibility
- IHE
- Local Government
- Non-Profit
- Other
- State Government
- Tribal Government
Additional Eligibility Information
Eligibility is limited to the national professional medical organizations authorized by the Drug Addiction Treatment Act of 2000 (DATA) to carry out the training of providers desiring to prescribe and/or dispense FDA-approved schedule III medications for the addictive disorders. These are the American Society of Addiction Medicine (ASAM), the American Academy of Addiction Psychiatry (AAAP), the American Medical Association (AMA), the American Osteopathic Academy of Addiction Medicine (AOAAM), and the American Psychiatric Association (APA).
Key Date(s)
- October 20, 2021: Last Updated Date
- October 20, 2021: Forecasted Date
- February 15, 2022: Estimated Post Date